SPECIALTY
GPCR pharmacology and target screening platform.
STAGE
Pre-clinical/clinical
POSITION
Lead
BOARD
Member
Domain Therapeutics has a world-leading GPCR target signalling platform, and two lead assets that can overcome checkpoint resistance in different tumors.